ThetaRay raised €7.3M in a Series B round in Jul 2014. The company is based in Jerusalem, Israel. Investors in the round: General Electric, Jerusalem Venture Partners, Poalim Capital Markets. Data as of 7 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
